The Woman’s Hospital of Texas and Designer Kendra Scott Team Up to Celebrate National Nurses Week
May 07, 2021 20:22 ET | HCA Houston Healthcare
Houston, Texas, May 07, 2021 (GLOBE NEWSWIRE) -- Hundreds of nurses at The Woman's Hospital of Texas were surprised with a special event this morning in honor of National Nurses Week.World-renowned...
cclogo.jpg
Canadian Council of Child and Youth Advocates calls for significant mental health planning and investment for young people now and after pandemic on National Child and Youth Mental Health Day
May 07, 2021 17:27 ET | Canadian Council of Child and Youth Advocates
SASKATOON, Saskatchewan, May 07, 2021 (GLOBE NEWSWIRE) -- COVID-19 is having major mental health consequences for children and youth across Canada and will have a lasting – and potentially...
CANADA-WIDE STUDY OF 3,000 YOUTH VAPERS SUPPORTS A COMPREHENSIVE FLAVOUR BAN ON NICOTINE VAPING PRODUCTS
May 07, 2021 11:08 ET | ASH Canada
Edmonton, Montreal, Ottawa, May 07, 2021 (GLOBE NEWSWIRE) -- Action on Smoking & Health (ASH Canada) • Advocates for a Smoke Free P.E.I. • Campaign for a Smoke-Free Alberta • Clean Air...
TIP_link_300x300.jpg
Dry Eye Products Market Growth Sturdy at 4.8% CAGR to Outstrip $9,141.01 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
May 07, 2021 09:30 ET | The Insight Partners
Pune, India., May 07, 2021 (GLOBE NEWSWIRE) -- Dry Eye Products Market: Key InsightsAccording to our new research study on “Dry Eye Products Market to 2027 – Global Analysis and Forecast – by...
PALI.jpg
Palisade Bio and Newsoara Announce Completion of Phase 2 Study in GI Surgery Study in China
May 07, 2021 09:07 ET | Palisade Bio, Inc.
CARLSBAD, Calif. and SHANGHAI, China, May 07, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), and co-development partner Newsoara today announce completion of a Phase 2 clinical trial...
medicenna.jpg
Medicenna Announces the Peer-Reviewed Publication of Clinical Data from Phase 2b Trial Evaluating MDNA55 in Recurrent Glioblastoma
May 07, 2021 09:00 ET | Medicenna Therapeutics Corp.
-- Data published in Clinical Cancer Research indicate that early determination of PFS with modified RANO criteria may be a strong surrogate for overall survival in recurrent glioblastoma --...
fnflogo1.jpg
Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Will Reach USD 16,487.4 Million by 2026: Facts & Factors
May 07, 2021 08:27 ET | Facts & Factors
New York, NY, May 07, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “B-Cell Maturation Antigen (BCMA) Targeted Therapies Market by Product Type (CAR-T cell,...
Top Reasons Why My Mom is a Superhero!
May 07, 2021 08:00 ET | Catholic Medical Mission Board
New York, New York, May 07, 2021 (GLOBE NEWSWIRE) -- CMMB helps provide access to improved and sustainable healthcare, focusing on vulnerable communities in low-resource countries. Much of the...
inozyme_logo.jpg
Inozyme Pharma Presents Preclinical Data Suggesting Utility of INZ-701 as a Potential Treatment for ABCC6 Deficiency
May 07, 2021 07:30 ET | Inozyme Pharma Inc.
BOSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization,...
KemPharm Logo
KemPharm Announces Serdexmethylphenidate (SDX) Has Been Classified as a Schedule IV Controlled Substance by the DEA
May 07, 2021 07:30 ET | KemPharm
KP879, KemPharm’s Lead Product Candidate Based on SDX and Intended for the Treatment of Stimulant Use Disorder (SUD), Could Be Schedule IV, If Approved by the FDA CELEBRATION, Fla., May 07, 2021 ...